Documentation
Real-world evidence of Besponsa in Belgium in acute lymphoblastic leukemia patients according to the prevailing reimbursement criteria
Dernière mise à jour: 2023-05-17 05:49
Implantable Continuous Glucose Monitoring under an agreement with limited clinical application
Dernière mise à jour: 2022-06-06 14:40